Apomorphine-induced disruption of prepulse inhibition that can be normalised by systemic haloperidol is insensitive to clozapine pretreatment

RationalePrepulse inhibition (PPI) of startle refers to the phenomenon in which a weak prepulse attenuates the startle response to a succeeding intense stimulus. PPI can be disrupted by systemic apomorphine in animals, and reduced PPI has been consistently reported in schizophrenia patients. The ability of the atypical antipsychotic clozapine to reverse apomorphine-induced PPI deficit has been demonstrated in the rat, but has not yet been tested in the mouse. The present study was designed to fill this gap.Objective and resultsWe investigated the efficacy of clozapine in reversing apomorphine-induced (2.0 or 2.5 mg/kg, SC) PPI deficit in C57BL6 mice. Clozapine failed to restore PPI disruption in apomorphine-treated mice in two independent laboratories across two dose ranges (1–3 mg/kg, IP, or 3–30 mg/kg, PO), whereas the typical antipsychotic haloperidol (1 mg/kg,IP) completely normalised PPI performance.ConclusionsUnlike the rat, apomorphine-induced PPI disruption in mice might be instrumental in distinguishing between typical and atypical antipsychotic drugs. This also lends further support to the suggestion that the neuropharmacology of PPI is not identical in the two rodent species.

[1]  Effects of phencyclidine (PCP) and (+)MK-801 on sensorimotor gating in CD-1 mice. , 1998, Progress in neuro-psychopharmacology & biological psychiatry.

[2]  H. Hoffman,et al.  ACOUSTIC VARIABLES IN THE MODIFICATION OF STARTLE REACTION IN THE RAT. , 1965, Journal of comparative and physiological psychology.

[3]  E. Zorrilla,et al.  Multiparous species present problems (and possibilities) to developmentalists. , 1997, Developmental psychobiology.

[4]  R. Depoortère,et al.  Potentiation of prepulse inhibition of the startle reflex in rats: pharmacological evaluation of the procedure as a model for detecting antipsychotic activity , 1997, Psychopharmacology.

[5]  G. Carey,et al.  Comparison of apomorphine, amphetamine and dizocilpine disruptions of prepulse inhibition in inbred and outbred mice strains. , 2001, European journal of pharmacology.

[6]  M. Geyer,et al.  Reversal of Startle Gating Deficits in Transgenic Mice Overexpressing Corticotropin-Releasing Factor by Antipsychotic Drugs , 2003, Neuropsychopharmacology.

[7]  M. Geyer,et al.  Mouse genetic models for prepulse inhibition: an early review , 2002, Molecular Psychiatry.

[8]  M. Geyer,et al.  Dopamine D1 Rather than D2 Receptor Agonists Disrupt Prepulse Inhibition of Startle in Mice , 2003, Neuropsychopharmacology.

[9]  M. Decker,et al.  Effects of phencyclidne (PCP) and (+)MK-801 on sensorimotor gating in CD-1 mice , 1998, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[10]  H. Ogura,et al.  Competitive NMDA receptor antagonists disrupt prepulse inhibition without reduction of startle amplitude in a dopamine receptor-independent manner in mice. , 1999, European journal of pharmacology.

[11]  M. Low,et al.  Differential Effects of Direct and Indirect Dopamine Agonists on Prepulse Inhibition: A Study in D1 and D2 Receptor Knock-Out Mice , 2002, The Journal of Neuroscience.